With extensive expertise in managing diverse investment portfolios, the fund manager has successfully executed over 30 deals across technology and healthcare sectors in North America and Europe. Emphasizing a data-driven investment strategy, they have achieved notable exits, including a significant return from a leading biotech firm. Their approach is characterized by a thematic focus on innovation and scalability, enabling them to identify high-potential opportunities at various stages of growth. This strategic style has consistently delivered strong performance and value creation for stakeholders.